Skip to main content

Farallon Capital Management, L.L.C.

13F filer · CIK 0000909661
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$21.7BU.S. long equity reported on 13F
Positions8218 new · 104 closed
Net flow last quarter-$3.42BBuys minus sells
Top 10 positions weight43.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202682 positions
RVMDRevolution Medicines, Inc.$2.54B11.71%6.33%-0.4%Q1 2020
EAElectronic Arts Inc.$1.62B7.49%Not reported+6.0%Q1 2026
BBIOBridgeBio Pharma, Inc.$800M3.69%5.50%+14.7%Q4 2023
PTGXProtagonist Therapeutics, Inc$778M3.59%9.82%Not reportedQ4 2017
EXELExelixis, Inc.$733M3.38%5.36%+2.7%Q2 2016
LQDALiquidia Corp$667M3.08%9.39%-3.4%Q2 2020
AMZNAmazon Com Inc$628M2.90%0.02%-37.6%Q2 2025
LNTHLantheus Holdings, Inc.$619M2.86%8.56%Not reportedQ2 2020
NTRANatera, Inc.$602M2.78%1.54%-30.8%Q2 2021
UNHUnitedhealth Group Inc$528M2.44%0.14%-30.3%Q3 2023
TMOThermo Fisher Scientific Inc.$526M2.43%0.28%+19.0%Q4 2019
ROIVRoivant Sciences Ltd.$506M2.34%1.98%+47.9%Q3 2023
AONAon plc$459M2.12%0.65%-45.0%Q2 2020
BSXBoston Scientific Corp$449M2.07%0.71%+40.8%Q3 2020
AVGOBroadcom Inc.$435M2.01%0.02%-35.3%Q4 2020
MSFTMicrosoft Corp$415M1.92%0.02%-52.5%Q3 2013
TNGXTango Therapeutics, Inc.$384M1.77%7.29%+35.0%Q3 2021
KKRKKR & Co. Inc.$378M1.74%0.46%-11.9%Q1 2026
SNPSSynopsys Inc$370M1.71%0.43%-31.6%Q1 2026
BEAMBeam Therapeutics Inc.$351M1.62%9.91%+1.0%Q1 2020
CRNXCrinetics Pharmaceuticals, Inc.$336M1.55%8.50%+7.8%Q4 2018
GRALGRAIL, Inc.$284M1.31%9.32%+27.9%Q2 2025
WABWestinghouse Air Brake Technologies Corp$241M1.11%0.53%-44.4%Q1 2017
IMVTImmunovant, Inc.$224M1.03%2.81%+275.5%Q3 2023
TWSTTwist Bioscience Corp$220M1.01%3.41%+49.6%Q2 2019
AGIOAgios Pharmaceuticals, Inc.$220M1.01%9.93%+4.1%Q4 2019
ARMKAramark$206M0.95%1.38%-40.9%Q4 2020
BIDUBaidu, Inc.$138M0.63%Not reported+171.3%Q3 2025
NVONovo Nordisk A S$126M0.58%Not reported+234.9%Q1 2026
ACHCAcadia Healthcare Company, Inc.$125M0.58%4.65%+143.0%Q4 2023
BTSGBrightSpring Health Services, Inc.$121M0.56%0.88%+7.2%Q1 2024
AZNAstrazeneca PLC$109M0.50%Not reported+153.4%Q4 2016
JNJJohnson & Johnson$104M0.48%0.02%+175.7%Q1 2026
PBLSParabilis Medicines, Inc.$64.8M0.30%1.94%NewQ2 2026
NVSNovartis AG$56.9M0.26%0.02%NewQ2 2026
GHGuardant Health, Inc.$48.3M0.22%0.24%+3927.5%Q2 2025
AVTXAvalo Therapeutics, Inc.$46.2M0.21%4.72%+172.7%Q1 2026
JOYYJOYY Inc.$46.1M0.21%Not reported+20.9%Q1 2025
ASMBAssembly Biosciences, Inc.$44.1M0.20%8.08%+30.7%Q4 2017
ENTAEnanta Pharmaceuticals Inc$35.3M0.16%8.30%-15.8%Q3 2017
MAZEMaze Therapeutics, Inc.$33.1M0.15%2.00%+197.0%Q1 2026
MRKMerck & Co., Inc.$25.6M0.12%0.01%-44.9%Q1 2026
WRBYWarby Parker Inc.$25.1M0.12%0.73%NewQ2 2026
FRNMFreenome, Inc.$24.5M0.11%25.25%Not reportedQ1 2026
KLRAKailera Therapeutics, Inc.$24.2M0.11%0.85%NewQ2 2026
RIORio Tinto PLC$17.4M0.08%0.01%+241.0%Q3 2023
AXTAAxalta Coating Systems Ltd.$16.4M0.08%0.22%NewQ2 2026
ABVXAbivax S.A.$16.3M0.08%0.16%+6000.0%Q3 2025
VNETVNET Group, Inc.$16M0.07%2.07%+219.6%Q2 2014
NTESNetEase, Inc.$15.8M0.07%0.00%-57.6%Q1 2026
Q1 2026Reported Aug 14, 2026168 positions
EAElectronic Arts Inc.$1.52B7.99%Not reportedNewQ1 2026
RVMDRevolution Medicines, Inc.$1.32B6.94%6.80%Not reportedQ1 2020
AMZNAmazon Com Inc$879M4.61%0.04%Not reportedQ2 2025
MSFTMicrosoft Corp$868M4.55%0.03%Not reportedQ3 2013
AONAon plc$811M4.25%1.17%Not reportedQ2 2020
BBIOBridgeBio Pharma, Inc.$695M3.65%4.79%Not reportedQ4 2023
PTGXProtagonist Therapeutics, Inc$669M3.51%9.89%Not reportedQ4 2017
NTRANatera, Inc.$641M3.36%2.25%Not reportedQ2 2021
EXELExelixis, Inc.$562M2.95%5.05%Not reportedQ2 2016
AVGOBroadcom Inc.$551M2.89%0.04%Not reportedQ4 2020
UNHUnitedhealth Group Inc$493M2.59%0.20%Not reportedQ3 2023
SNPSSynopsys Inc$481M2.52%0.63%NewQ1 2026
BSXBoston Scientific Corp$469M2.46%0.50%Not reportedQ3 2020
TMOThermo Fisher Scientific Inc.$433M2.27%0.24%Not reportedQ4 2019
KKRKKR & Co. Inc.$432M2.27%0.53%NewQ1 2026
LNTHLantheus Holdings, Inc.$424M2.22%8.58%Not reportedQ2 2020
WABWestinghouse Air Brake Technologies Corp$402M2.11%0.95%Not reportedQ1 2017
SCHWSchwab Charles Corp$372M1.95%0.23%Not reportedQ2 2014
LQDALiquidia Corp$327M1.71%9.80%Not reportedQ2 2020
CRNXCrinetics Pharmaceuticals, Inc.$303M1.59%7.92%Not reportedQ4 2018
GOOGAlphabet Inc.$286M1.50%Not reportedNot reportedQ4 2015
ROIVRoivant Sciences Ltd.$268M1.41%1.34%Not reportedQ3 2023
VVisa Inc.$254M1.33%0.04%Not reportedQ2 2013
ARMKAramark$249M1.30%2.33%Not reportedQ4 2020
BEAMBeam Therapeutics Inc.$242M1.27%9.86%Not reportedQ1 2020
DISWalt Disney Co$231M1.21%0.14%Not reportedQ2 2013
MAMastercard Inc$217M1.14%0.04%Not reportedQ1 2021
MCKMckesson Corp$203M1.06%0.19%Not reportedQ1 2014
AGIOAgios Pharmaceuticals, Inc.$192M1.01%9.58%Not reportedQ4 2019
CNTACentessa Pharmaceuticals PLC$191M1.00%3.11%Not reportedQ1 2024
TNGXTango Therapeutics, Inc.$190M1.00%6.31%Not reportedQ3 2021
GRALGRAIL, Inc.$168M0.88%7.91%Not reportedQ2 2025
TYRATyra Biosciences, Inc.$137M0.72%6.02%Not reportedQ4 2024
THCTenet Healthcare Corp$85.3M0.45%0.52%Not reportedQ3 2023
CAHCardinal Health Inc$77.8M0.41%0.16%Not reportedQ1 2025
PCVXVaxcyte, Inc.$73.3M0.38%0.87%Not reportedQ4 2023
DNTHDianthus Therapeutics, Inc.$70.2M0.37%1.53%NewQ1 2026
BTSGBrightSpring Health Services, Inc.$68.9M0.36%0.84%Not reportedQ1 2024
TWSTTwist Bioscience Corp$67.8M0.36%2.30%Not reportedQ2 2019
BIDUBaidu, Inc.$49.4M0.26%Not reportedNot reportedQ3 2025
CGONCG Oncology, Inc.$45.6M0.24%0.77%Not reportedQ2 2025
AZNAstrazeneca PLC$44.7M0.23%Not reportedNot reportedQ4 2016
MRKMerck & Co., Inc.$43.4M0.23%0.01%NewQ1 2026
ACHCAcadia Healthcare Company, Inc.$40.6M0.21%1.91%Not reportedQ4 2023
WELLWelltower Inc.$39.5M0.21%0.03%NewQ1 2026
IMVTImmunovant, Inc.$38.4M0.20%0.76%Not reportedQ3 2023
ENTAEnanta Pharmaceuticals Inc$36.3M0.19%9.88%Not reportedQ3 2017
JNJJohnson & Johnson$36.2M0.19%0.01%NewQ1 2026
BBNXBeta Bionics, Inc.$36.2M0.19%8.10%Not reportedQ1 2025
ASMBAssembly Biosciences, Inc.$34.1M0.18%7.72%Not reportedQ4 2017
Q3 2025Reported Feb 17, 2026137 positions
MSFTMicrosoft Corp$991M4.06%0.03%+9.5%Q3 2013
AONAon plc$812M3.33%1.06%+14.7%Q2 2020
EXELExelixis, Inc.$805M3.30%7.24%+21.6%Q2 2016
AMZNAmazon Com Inc$770M3.15%0.03%+15.5%Q2 2025
NTRANatera, Inc.$685M2.80%3.09%-11.8%Q2 2021
RVMDRevolution Medicines, Inc.$683M2.80%7.71%+2.1%Q1 2020
UNHUnitedhealth Group Inc$651M2.67%0.21%+16.7%Q3 2023
TMOThermo Fisher Scientific Inc.$610M2.50%0.33%-9.0%Q4 2019
HIMSHims & Hers Health, Inc.$610M2.50%Not reported+30.8%Q3 2023
DISWalt Disney Co$595M2.44%0.27%+6.7%Q2 2013
CRMSalesforce, Inc.$584M2.39%0.26%+16.8%Q4 2019
ADSKAutodesk, Inc.$528M2.16%0.78%-4.7%Q4 2024
BSXBoston Scientific Corp$463M1.90%0.32%+19.2%Q3 2020
IBITiShares Bitcoin Trust ETF$455M1.86%0.54%-0.4%Q3 2024
WABWestinghouse Air Brake Technologies Corp$442M1.81%1.29%+68.6%Q1 2017
BBIOBridgeBio Pharma, Inc.$425M1.74%4.25%+3.7%Q4 2023
PTGXProtagonist Therapeutics, Inc$412M1.68%9.92%+0.4%Q4 2017
TRUTransUnion$396M1.62%2.44%-12.4%Q3 2017
ARMKAramark$345M1.41%3.42%-30.3%Q4 2020
INTUIntuit Inc.$333M1.36%0.18%-9.1%Q4 2022
NDAQNasdaq, Inc.$320M1.31%0.63%-11.3%Q3 2023
ADIAnalog Devices Inc$319M1.31%0.26%+2.2%Q3 2023
SCHWSchwab Charles Corp$310M1.27%0.18%-17.9%Q2 2014
NYTNew York Times Co$286M1.17%Not reported-11.1%Q2 2020
GOOGAlphabet Inc.$273M1.12%Not reported-36.4%Q4 2015
CBRECbre Group, Inc.$255M1.04%0.54%-23.5%Q3 2023
MCKMckesson Corp$253M1.03%0.26%+4.0%Q1 2014
BEAMBeam Therapeutics Inc.$244M1.00%9.93%+0.5%Q1 2020
CRNXCrinetics Pharmaceuticals, Inc.$240M0.98%6.10%+24.2%Q4 2018
ETHAiShares Ethereum Trust ETF$235M0.96%1.86%NewQ3 2025
AGIOAgios Pharmaceuticals, Inc.$232M0.95%9.92%+0.2%Q4 2019
VVisa Inc.$205M0.84%0.03%+94.2%Q2 2013
LQDALiquidia Corp$195M0.80%9.87%+102.1%Q2 2020
NSCNorfolk Southern Corp$185M0.76%0.27%NewQ3 2025
LNTHLantheus Holdings, Inc.$178M0.73%4.85%-48.3%Q2 2020
IQVIqvia Holdings Inc.$178M0.73%0.55%-75.6%Q4 2017
WWDWoodward, Inc.$157M0.64%1.04%-32.0%Q3 2024
MAMastercard Inc$122M0.50%0.02%+40.6%Q1 2021
CNTACentessa Pharmaceuticals PLC$105M0.43%3.22%-4.4%Q1 2024
TEVATeva Pharmaceutical Industries Ltd$101M0.41%0.44%NewQ3 2025
TNGXTango Therapeutics, Inc.$90.4M0.37%9.64%+17.5%Q3 2021
BBNXBeta Bionics, Inc.$85.7M0.35%9.81%+2.6%Q1 2025
THCTenet Healthcare Corp$84.1M0.34%0.47%-21.7%Q3 2023
GRALGRAIL, Inc.$79.8M0.33%3.73%+168.7%Q2 2025
EHCEncompass Health Corp$72.5M0.30%0.57%-19.4%Q3 2023
OSCROscar Health, Inc.$68.9M0.28%Not reported+146.5%Q1 2024
ABVXAbivax S.A.$68.3M0.28%1.27%NewQ3 2025
MARAMARA Holdings, Inc.$66.8M0.27%0.97%+338.3%Q4 2024
MLYSMineralys Therapeutics, Inc.$63.4M0.26%2.12%NewQ3 2025
VNETVNET Group, Inc.$56.7M0.23%5.70%+83.3%Q2 2014
Q2 2025Reported Feb 17, 2026139 positions
SPYSPDR S&P 500 ETF Trust$3.4B14.28%Not reportedNot reportedQ4 2024
MSFTMicrosoft Corp$869M3.65%0.02%-23.5%Q3 2013
NTRANatera, Inc.$815M3.42%3.53%+6.0%Q2 2021
HESHess Corp$804M3.38%Not reported+7.0%Q4 2023
AONAon plc$709M2.98%0.92%+45.9%Q2 2020
EXELExelixis, Inc.$707M2.97%5.88%-28.8%Q2 2016
AMZNAmazon Com Inc$666M2.80%0.03%NewQ2 2025
IQVIqvia Holdings Inc.$607M2.55%2.27%+12.9%Q4 2017
DISWalt Disney Co$604M2.54%0.27%-11.3%Q2 2013
CRMSalesforce, Inc.$575M2.42%0.22%+7.2%Q4 2019
TMOThermo Fisher Scientific Inc.$561M2.36%0.37%+33.5%Q4 2019
LNTHLantheus Holdings, Inc.$550M2.31%9.38%+11.6%Q2 2020
ARMKAramark$540M2.27%4.91%-20.6%Q4 2020
ADSKAutodesk, Inc.$540M2.27%0.82%-12.7%Q4 2024
RVMDRevolution Medicines, Inc.$527M2.21%7.66%+5.8%Q1 2020
UNHUnitedhealth Group Inc$505M2.12%0.18%+8.0%Q3 2023
TRUTransUnion$476M2.00%2.77%-0.2%Q3 2017
IBITiShares Bitcoin Trust ETF$430M1.81%0.66%+21.2%Q3 2024
BSXBoston Scientific Corp$428M1.80%0.27%+5.8%Q3 2020
INTUIntuit Inc.$423M1.78%0.19%-36.1%Q4 2022
LBRDKLiberty Broadband Corp$421M1.77%Not reportedNot reportedQ3 2024
HIMSHims & Hers Health, Inc.$409M1.72%Not reported+3.3%Q3 2023
NDAQNasdaq, Inc.$365M1.53%0.71%-8.4%Q3 2023
SCHWSchwab Charles Corp$361M1.52%0.22%+3.3%Q2 2014
ANSSAnsys Inc$350M1.47%1.13%+5.2%Q1 2024
PTGXProtagonist Therapeutics, Inc$341M1.43%9.94%+1.1%Q4 2017
BBIOBridgeBio Pharma, Inc.$341M1.43%4.13%+37.9%Q4 2023
NYTNew York Times Co$314M1.32%Not reported-37.2%Q2 2020
GOOGAlphabet Inc.$313M1.31%Not reported+5.8%Q4 2015
ADIAnalog Devices Inc$303M1.27%0.26%-4.1%Q3 2023
CBRECbre Group, Inc.$296M1.24%0.71%-15.3%Q3 2023
WABWestinghouse Air Brake Technologies Corp$274M1.15%0.77%-18.7%Q1 2017
MCKMckesson Corp$231M0.97%0.25%-43.1%Q1 2014
WWDWoodward, Inc.$224M0.94%1.54%-35.6%Q3 2024
AGIOAgios Pharmaceuticals, Inc.$192M0.81%9.94%+1.2%Q4 2019
VRNAVerona Pharma plc$171M0.72%0.26%+66.8%Q1 2025
AZEKThe AZEK Company Inc.$171M0.72%Not reported+175.6%Q1 2025
BEAMBeam Therapeutics Inc.$170M0.72%9.94%+0.9%Q1 2020
CRNXCrinetics Pharmaceuticals, Inc.$134M0.56%4.94%+0.9%Q4 2018
VVisa Inc.$110M0.46%0.02%-34.9%Q2 2013
CHXChampionX Corp$105M0.44%2.22%+46.1%Q2 2024
GEHCGE HealthCare Technologies Inc.$97.9M0.41%0.29%+146.2%Q4 2024
THCTenet Healthcare Corp$93.1M0.39%0.57%Not reportedQ3 2023
EHCEncompass Health Corp$86.8M0.36%0.70%+14.4%Q3 2023
MAMastercard Inc$85.5M0.36%0.01%-24.5%Q1 2021
CAHCardinal Health Inc$76.3M0.32%0.19%+66.3%Q1 2025
EDUNew Oriental Education & Technology Group Inc.$62.3M0.26%0.07%-11.5%Q3 2013
BBNXBeta Bionics, Inc.$61.2M0.26%9.67%+26.2%Q1 2025
CNTACentessa Pharmaceuticals PLC$59.5M0.25%3.38%+4.5%Q1 2024
AMEDAmedisys Inc$56.6M0.24%1.75%+9.5%Q3 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.